Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-03-000163
Filing Date
2003-03-31
Accepted
2003-03-31 14:26:11
Documents
9
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2107125z10-k.htm 10-K 709469
3 EXHIBIT 3.7 a2107125zex-3_7.htm EX-3.7 16703
4 EXHIBIT 10.33 a2107125zex-10_33.htm EX-10.33 43687
5 EXHIBIT 10.34 a2107125zex-10_34.htm EX-10.34 1506
6 EXHIBIT 10.35 a2107125zex-10_35.htm EX-10.35 53548
7 EXHIBIT 10.36 a2107125zex-10_36.htm EX-10.36 52522
8 EXHIBIT 10.37 a2107125zex-10_37.htm EX-10.37 53188
9 EXHIBIT 23.1 a2107125zex-23_1.htm EX-23.1 1636
10 EXHIBIT 23.2 a2107125zex-23_2.htm EX-23.2 1631
  Complete submission text file 0000912057-03-000163.txt   936338
Mailing Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601
Business Address 433 HACKENSACK AVENUE HACKENSACK NJ 07601 2019680980
DOV PHARMACEUTICAL INC (Filer) CIK: 0001066833 (see all company filings)

EIN.: 223374365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-49730 | Film No.: 03629167
SIC: 2834 Pharmaceutical Preparations